NEW HORIZON HEALTH LIMITED Funds and ETFs New Horizon Health Limited
Equities
6606
KYG6485S1021
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.14 HKD | -19.75% |
|
-.--% | -38.92% |
| Apr. 08 | New Horizon Health Limited Announces Board Appointments | CI |
| Mar. 28 | New Horizon Health Limited Announces Delay in Publication Annual Results for the Year Ended December 31, 2023 | CI |
ETFs positioned on New Horizon Health Limited
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.12% | 4 M€ | -27.92% | ||
| 0.11% | 2 M€ | -14.14% | ||
| 0.01% | 4 M€ | -4.41% | - | |
| 0.01% | 117 M€ | +1.11% | - | |
| 0.00% | 34 M€ | +2.14% | - | |
| 0.00% | 7 M€ | +1.95% | - |
New Horizon Health Ltd is a China-based investment holding company principally engaged in the research, development, clinical development, test operation and commercialization of screening products for colorectal cancer, gastric cancer and cervical cancer. The Company distributes its ColoClear, Pupu tube and other products to customers through its own network, contracted sales organisations (CSOs) and Internet sales or e-platform operated by healthcare clinics. The Companyâs Youyou Tube (a stool-based self-checking gastric cancer screening test) and CerviClear (a non-invasive urine cervical cancer home screening test) are under development.
Calendar
2024-08-15
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
13.06
CNY
Average target price
32.48
CNY
Spread / Average Target
+148.69%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -38.92% | 811M | |
| +0.89% | 12.8B | |
| -10.29% | 7.61B | |
| +1.78% | 5.41B | |
| -1.16% | 4.51B | |
| +5.74% | 4.49B | |
| -50.70% | 3.29B | |
| +12.21% | 2.73B | |
| -16.13% | 2.02B | |
| -11.50% | 1.73B |
- Stock Market
- Equities
- 6606 Stock
- Funds and ETFs New Horizon Health Limited
